What You Should Know:
– Creyos, an online platform for objective cognitive and behavioral health assessments, today announced a strategic partnership with Redox, a prominent provider of healthcare data interoperability solutions.
– The collaboration is set to enable large health systems and integrated delivery networks to seamlessly embed Creyos’ validated cognitive testing tools directly into their existing electronic health records (EHRs), effectively dismantling one of the most significant barriers to scaling proactive brain health care.
The Growing Imperative for Proactive Brain Health
The need for accessible and efficient cognitive assessment tools is becoming increasingly critical. With over 55 million people worldwide currently living with dementia—a figure projected to soar to 139 million by 2050—early and accurate screening is paramount. Such screenings enable timely intervention, personalized care planning, and ultimately, improved patient outcomes. As healthcare systems increasingly shift towards value-based care models, Creyos is focused on helping providers integrate cognitive health as a core component of routine and preventive care, utilizing tools that are both clinically proven and straightforward to implement.
Overcoming Implementation Hurdles with Seamless Integration
A common challenge for new health technologies is gaining traction within large health systems, often due to poor alignment with existing clinical workflows and complex integration processes. This new Creyos-Redox partnership directly addresses these issues. By leveraging Redox’s expansive EHR network, which supports interoperability across more than 90 EHR systems including major platforms like Cerner, eClinicalWorks, and Allscripts, Creyos can deliver seamless data integration and platform access. This means Creyos’ scientifically validated dementia screening and cognitive assessments will be readily available to clinicians at the point of care, directly within the systems they use daily.
“We’re at a turning point in how health systems approach cognitive health,” said Marc Lipton, CEO of Creyos. “To deliver on the promise of value-based care, we need tools that don’t just work clinically but also work operationally. This partnership with Redox eliminates the workflow and integration barriers that have slowed adoption for years. It puts Creyos assessments exactly where they need to be, within the systems clinicians already use.”
Creyos-Redox EHR Integration Benefits
Health systems deploying Creyos through this strategic partnership can expect several key advantages:
- Timely Decision-Making: Providers will receive cognitive screener and assessment data directly within their existing EHR systems. This facilitates faster clinical decision-making, allows for quicker interventions, and supports more coordinated care planning.
- Improved Clinical Workflow Efficiency: The automation of integrating cognitive test results significantly reduces administrative burdens on clinical staff, freeing up more valuable time for direct patient care and interaction.
- Scalability for Large Health Systems: Whether an organization is supporting a single location or a national network of clinics, the Creyos-Redox integration is designed to be highly scalable and adaptable to the unique needs of any enterprise healthcare system.
- Early Detection and Proactive Care: Cognitive health is a critical element of preventive care, especially for aging populations and at-risk patient groups. By embedding Creyos’ assessments into EHRs, providers can more effectively monitor for cognitive decline over time, ensuring they catch early warning signs of conditions like dementia or mild cognitive impairment (MCI) before they progress further.
The Creyos EHR integration through Redox is now available for all Creyos customers. Health systems interested in learning more about integrating Creyos’ cognitive assessments into their practice can visit www.creyos.com.
